DLK1‐directed chimeric antigen receptor T‐cell therapy for hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Liver International"
DOI: 10.1111/liv.15411
Abstract: Delta‐like homologue 1 (DLK1), a transmembrane protein, is highly expressed in hepatocellular carcinoma (HCC). We explored whether DLK1‐directed chimeric antigen receptor (CAR) T cells can specifically eliminate DLK1‐positive HCC cells and serve as a therapeutic… read more here.
Keywords: directed chimeric; hepatocellular carcinoma; antigen receptor; chimeric antigen ... See more keywords